Mike Jandernoa was CEO of Perrigo Company from 1988 to 2000, Chairman of the Board from 1991 to 2003, and continues to serve on the Board of Directors. Perrigo is a leading global healthcare supplier that develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals.
Mike is a graduate of the University of Michigan and was a CPA, having worked at BDO Seidman for seven years prior to joining Perrigo in 1979. Hired by Perrigo as CFO, Mike was promoted to EVP of Sales and Finance in 1981, appointed President in January 1983, and became CEO in 1988. He was promoted to Chairman of the Board and CEO in November 1991, a position he held until May of 2000. During his career at Perrigo, Mike helped lead two LBO’s in 1981 and 1988 and the IPO in 1991.
In addition to his service on Perrigo’s Board of Directors, he also serves on the Board of Directors of Business Leaders for Michigan (BLM), the Van Andel Institute, Hopen Life Science Fund, Metabolic Solutions Development Company (MSDC), the University of Michigan President’s Advisory Board, Grand Valley University Foundation, and Gerald R. Ford Presidential Foundation. Mike is a member of other corporate advisory boards and is a past member of the Young Presidents’ Organization. Mike also serves/chairs on numerous religious and community boards and committees as well.
In addition, Mike is the founder of Jandernoa Entrepreneurial Mentoring. He is a co-founder of Bridge Street Capital Partners, lead investor and Board member of Hopen Life Science Fund, and co-founder of Grand Angels. Mike is the founder and Chairman of 42 North Partners, a family office focusing on investments, entrepreneurship, and community.